Esperion
ESPREsperion Therapeutics, Inc. is a public American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.
© Wikipedia /
Creative Commons CC-BY-SA 3.0 more at Wikipedia
Insider trades and stock quote 2021/2020
All insider trades at Esperion
Subscribe RSS| Date | Type | Insider | Position | Ø-Price | Volume |
|---|---|---|---|---|---|
| 11/3/2020 | Buy | Biotech, Target N V. | Ten Percent Owner | $25.3 | $5,062,120 |
| 3/11/2020 | Buy | Mayleben, Timothy M. | President & CEO | $43.0 | $107,500 |
| 2/28/2020 | Buy | Mayleben, Timothy M. | President & CEO | $49.0 | $245,000 |
| 1/23/2020 | Buy | Biotech, Target N V. | Ten Percent Owner | $52.1 | $1,042,398 |
All information without guarantee! No recommendation/consultation!
© U.S. Securities and Exchange Commission (SEC)